BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
DRD2
,
G-protein-coupled receptor binding
,
Lung cancer
,
Liver
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
B cell lymphoma protein- 2
Summary
General Info
Curated Studies
Most Correlated Studies
B-cell lymphoma cell lines treated by 92 FDA approved compounds - a timecourse
Diffuse large B-cell lymphoma and primary transformed or relapsed follicular lymphoma tissues
Lymph nodes from diffuse large B-cell lymphoma (DLBCL) patients
Diffuse large B cell lymphomas from brains of primary CNS lymphoma patients
Cooperative Signaling in the STAT3 and NF-kB Pathways in Subtypes of diffuse large B cell lymphoma
Explore Curated Studies Results
Literature
Most Relevant Literature
B-cell lymphoma-2 family proteins in the crosshairs: Small molecule inhibitors and activators for ca…
Impact of BCL-2 Expression on Course of Disease in Neuroblastoma.
Exosomes of endothelial progenitor cells repair injured vascular endothelial cells through the Bcl2/…
Molecular-Scale Investigations Reveal the Effect of Natural Polyphenols on BAX/Bcl-2 Interactions.
Enhancing dendritic cells by inhibiting BCL2.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Efficiency Study of CD19-PD1-CART Cell in Relapsed/Refractory B Cell Lymphoma
Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germi…
Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin L…
A Phase 1/2 Study of CT120 in Patient With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Zevalin Plus BuCyE High-dose Therapy in B-cell Non-Hodgkin's Lymphoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ